(140 days)
No
The summary describes a device for data acquisition and transmission, with no mention of AI/ML algorithms for analysis or interpretation of the collected physiological data. The performance studies focus on data capture, connectivity, and hardware performance, not algorithmic performance.
No.
The device is intended to record, display, and store physiological data to aid in diagnosis and treatment. It is a diagnostic monitoring technology, not a therapeutic one.
Yes
The "Intended Use / Indications for Use" section states, "The device is intended for use when the clinician decides to evaluate the physiologic signals as an aid to diagnosis and treatment." Additionally, the "Device Description" explicitly refers to the device as "the next generation diagnostic monitoring technology."
No
The device description clearly outlines three hardware components: the SimpleSENSE Garment with embedded sensors, the SimpleSENSE Signal Acquisition Unit (SAU) for data acquisition and transmission, and the SimpleSENSE Mobile Application. The performance studies also include verification and testing of these hardware components.
Based on the provided information, the SimpleSENSE System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body, such as blood, urine, or tissue, to provide information for diagnosis, monitoring, or screening.
- SimpleSENSE Function: The SimpleSENSE System directly measures physiological signals (ECG, respiration, heart sounds, activity) from the patient's body using sensors embedded in a garment. It does not analyze specimens taken from the body.
- Intended Use: The intended use describes the device as recording, displaying, and storing physiological data as an aid to diagnosis and treatment. This is consistent with a physiological monitoring or recording device, not an IVD.
Therefore, the SimpleSENSE System falls under the category of a physiological monitoring or recording device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The SimpleSENSE System is intended for use at home, or at a healthcare facility, under the direction of a licensed medical professional, to record, display and store the following physiological data: a) 2 leads of Electrocardiogram; b) Respiration rate measured through thoracic impedance; c) Heart Sounds; and d) Activity including posture. The device is intended for use when the clinician decides to evaluate the physiologic signals as an aid to diagnosis and treatment. The SimpleSENSE System is intended to be used by patients at rest and not performing any activities or movements. ECG recordings are indicated for the manual assessment of cardiac rhythm disturbances. The device does not produce alarms and is not intended for active patient monitoring (real-time). The device is not intended for use as life supporting equipment on high-risk patients such as critical care patients. The device is not intended for use in the presence of a pacemaker.
Product codes (comma separated list FDA assigned to the subject device)
DXH, DSB, BZQ, DPS, DQD
Device Description
The Nanowear SimpleSENSE device is the next generation diagnostic monitoring technology that captures electrocardiographic (ECG) signals, respiration rate though thoracic impedance, heart sounds, activity including posture with sensors embedded on a wearable textile garment. The signals are stored and wirelessly transmitted to a smartphone, and forwarded to a medical professional for review.
The garment is designed to be unobtrusive to everyday activity and provide an easy and efficient means of capturing ECG, respiration rate, heart sounds and activity data from patients.
The garment is designed to be unobtrusive to everyday activity and provide an easy and efficient means of capturing ECG data from patients. The device consists of three (3) components:
- The SimpleSENSE Garment: an integrated network of nanosensor electrodes for measuring ECG and respiratory rate from thoracic impedance, and incorporating a MEMS microphone for measuring heart sounds.
- The SimpleSENSE Signal Acquisition Unit (SAU): data acquisition, storage, and transmission to an iPhone 7 using iOS 13.4. Incorporates an accelerometer to measure activity.
- The SimpleSENSE Mobile Application: mobile application for to start/stop a recording and to forward the test report to the medical professional.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult patients
Intended User / Care Setting
Home, or at a healthcare facility, under the direction of a licensed medical professional
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing for the SimpleSENSE device included the following:
• Verification of multiparametric data capture
• Verification of Bluetooth and iPhone connectivity
• Verification of encryption of acquired data
• Battery safety and charging status indication
• SAU performance and durability
• Durability, capacity, and data storage testing of the microSD card
• Battery charger verification
• Biocompatibility of the garment
• Electrocardiograph sensor performance
• Electrical current requirements for transthoracic impedance sensor
• MEMS microphone testing
• Garment conductive inlays testing for flexibility and electrical performance
• Garment compression requirements
• Garment fastening mechanisms
• Use cycles for the base garment
• Shelf life
• Equivalency testing against predicate/reference devices
Performance testing demonstrated performance to design specifications.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K161431 SimplECG
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2920 Telephone electrocardiograph transmitter and receiver.
(a)
Identification. A telephone electrocardiograph transmitter and receiver is a device used to condition an electrocardiograph signal so that it can be transmitted via a telephone line to another location. This device also includes a receiver that reconditions the received signal into its original format so that it can be displayed. The device includes devices used to transmit and receive pacemaker signals.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: a symbol on the left and the text "FDA U.S. FOOD & DRUG ADMINISTRATION" on the right. The symbol on the left is a stylized image of a human figure, and the text on the right is in blue. The text is arranged in three lines, with "FDA" on the first line, "U.S. FOOD & DRUG" on the second line, and "ADMINISTRATION" on the third line.
November 6, 2020
Nanowear Inc. % Melissa Walker President & CTO Graematter, Inc. 1324 Clarkson Clayton Ctr, #332 St Louis, Missouri 63011
Re: K201669
Trade/Device Name: SimpleSENSE Regulation Number: 21 CFR 870.2920 Regulation Name: Telephone Electrocardiograph Transmitter And Receiver Regulatory Class: Class II Product Code: DXH, DSB, BZQ, DPS, DQD Dated: October 4, 2020 Received: October 6, 2020
Dear Melissa Walker:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Jennifer Shih Assistant Director Division of Cardiac Electrophysiology, Diagnostics and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K201669
Device Name Simple SENSE
Indications for Use (Describe)
The SimpleSENSE System is intended for use at home, or at a healthcare facility, under the direction of a licensed medical professional, to record, display and store the following physiological data: a) 2 leads of Electrocardiogram; b) Respiration rate measured through thoracic impedance; c) Heart Sounds; and d) Activity including posture. The device is intended for use when the clinician decides to evaluate the physiologic signals as an aid to diagnosis and treatment. The SimpleSENSE System is intended to be used by patients at rest and not performing any activities or movements. ECG recordings are indicated for the manual assessment of cardiac rhythm disturbances. The device does not produce alarms and is not intended for active patient monitoring (real-time). The device is not intended for use as life supporting equipment on high-risk patients such as critical care patients. The device is not intended for use in the presence of a pacemaker.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
K201669 510(k) Summary
Submitter's information
Nanowear, Inc. 53 Boerum Pl, Suite 3F Brooklyn, NY 11201 United States 718-637-4815
Contact: Venk Varadan 53 Boerum Pl, Suite 3F Brooklyn, NY 11201 United States Phone: 718-637-4815 Date: June 15 2020
Classification The classification for the new device is shown in the table below.
| 21 CFR
Reference | Product
Code | Class | Trade Name | Classification Name |
|---------------------|-----------------|-------|-------------|--------------------------------------------------------------|
| §870.2920 | DXH | 2 | | Transmitters and Receivers,
Electrocardiograph, Telephone |
| §870.2770 | DSB | 2 | SimpleSENSE | Plethysmograph, Impedance |
| §868.2375 | BZQ | 2 | SimpleSENSE | Monitor, Breathing Frequency |
| §870.2340 | DPS | 2 | SimpleSENSE | Electrocardiograph |
| §870.1875 | DQD | 2 | SimpleSENSE | Stethoscope, Electronic |
Predicate The predicate device is: devices · K161431 SimplECG cleared on 11/30/2016 from Nanowear, Inc. The following devices are considered as reference devices: • K160981 Patient Monitor, models elite V5, elite V6 and elite V8 cleared on 12/22/2016 from Edan Instruments, Inc. • K151319 Eko Electronic Stethoscope System cleared on 5/18/2015 from Eko Devices, Inc. The SimpleSENSE System is intended for use at home, or at a healthcare facility, under Indications for use the direction of a licensed medical professional, to record, display and store the following physiological data: a) 2 leads of Electrocardiogram; b) Respiration rate measured through thoracic impedance; c) Heart Sounds; and d) Activity including posture. The device is intended for use when the clinician decides to evaluate the physiologic signals of adult patients as an aid to diagnosis and treatment. The SimpleSENSE System is intended to be used by patients at rest and not performing any activities or movements. ECG recordings are indicated for the manual assessment of cardiac rhythm disturbances. The device does not produce alarms and is not intended for active patient monitoring (real-time). The device is not intended for use as life supporting equipment on high-risk patients such as critical care patients. The device is not intended for use in the presence of a pacemaker.
4
Device The Nanowear SimpleSENSE device is the next generation diagnostic description monitoring technology that captures electrocardiographic (ECG) signals, respiration rate though thoracic impedance, heart sounds, activity including posture with sensors embedded on a wearable textile garment. The signals are stored and wirelessly transmitted to a smartphone, and forwarded to a medical professional for review.
The garment is designed to be unobtrusive to everyday activity and provide an easy and efficient means of capturing ECG, respiration rate, heart sounds and activity data from patients.
The garment is designed to be unobtrusive to everyday activity and provide an easy and efficient means of capturing ECG data from patients. The device consists of three (3) components:
- The SimpleSENSE Garment: an integrated network of nanosensor electrodes for measuring ECG and respiratory rate from thoracic impedance, and incorporating a MEMS microphone for measuring heart sounds.
- The SimpleSENSE Signal Acquisition Unit (SAU): data acquisition, storage, and transmission to an iPhone 7 using iOS 13.4. Incorporates an accelerometer to measure activity.
- The SimpleSENSE Mobile Application: mobile application for to start/stop a recording and to forward the test report to the medical professional.
5
Characteristics | The table below provides a comparison of the New Device with the predicate and reference devices. | ||||
---|---|---|---|---|---|
Characteristic | Nanowear Inc. | ||||
SimpleSENSE - New | |||||
Device | |||||
Current Submission | Nanowear Inc. SimplECG | ||||
K161431 | Edan Instruments, Patient | ||||
Monitor, models elite V5, | |||||
elite V6 and elite V8 | |||||
K160981 | Eko Devices Inc. Eko | ||||
Electronic | |||||
Stethoscope System | |||||
K151319 | Comparison | ||||
Indications for | |||||
Use Statement | The SimpleSENSE system is | ||||
intended for use at home, | |||||
or healthcare facility, under | |||||
the direction of a licensed | |||||
medical professional, to | |||||
record, display and store | |||||
the following physiological | |||||
data: a) 2 leads of | |||||
Electrocardiogram b) | |||||
Respiration rate measured | |||||
through thoracic | |||||
impedance; c) Heart | |||||
Sounds; and d) Activity | |||||
including posture. The | |||||
device is intended for use | |||||
when the clinician decides | |||||
to evaluate the physiologic | |||||
signals of adult patients as | |||||
an aid to diagnosis and | |||||
treatment. The | |||||
SimpleSENSE System is | |||||
intended to be used by | |||||
patients at rest and not | |||||
performing any activities or | |||||
movements. ECG | The SimplECG is intended | ||||
to aid in the diagnostic | |||||
evaluation of patients, 21 | |||||
years of age and above, on | |||||
the order of a physician, | |||||
who experience transient | |||||
symptoms which may | |||||
suggest the need for | |||||
monitoring to manually | |||||
assess their cardiac rhythm | |||||
disturbance. ECG data is | |||||
recorded, stored, | |||||
transferred and displayed | |||||
wirelessly for review by a | |||||
physician who is skilled in | |||||
rhythm interpretation. | The monitors are intended | ||||
to be used for monitoring, | |||||
storing, and reviewing of, | |||||
and to generate alarms for, | |||||
multiple physiological | |||||
parameters of adults, | |||||
pediatrics and neonates. | |||||
The monitors are intended | |||||
for use by trained | |||||
healthcare professionals in | |||||
hospital environments. The | |||||
monitored physiological | |||||
parameters include: ECG, | |||||
respiration (RESP), | |||||
temperature (TEMP), | |||||
oxygen saturation of | |||||
arterial blood (SpO2), pulse | |||||
rate (PR), non-invasive | |||||
blood pressure (NIBP), | |||||
invasive blood pressure | |||||
(IBP), carbon dioxide | |||||
(CO2), cardiac output | |||||
(C.O.), anesthetic gas (AG), | |||||
bispectral index (BIS), | |||||
respiration mechanics (RM) | The Eko Electronic | ||||
Stethoscope System is | |||||
intended to be used as | |||||
a part of a physical | |||||
assessment of a | |||||
patient by healthcare | |||||
professionals for | |||||
diagnostic decision | |||||
support in clinical | |||||
settings. Eko is | |||||
intended for use on | |||||
pediatric and adult | |||||
patients. It can | |||||
electronically amplify, | |||||
filter and transfer | |||||
sounds to the | |||||
accompanying mobile | |||||
application for storage | |||||
and sharing. It can | |||||
used to record heart | |||||
sounds and cardiac | |||||
murmurs, bruits, | |||||
respiratory sounds and | |||||
abdominal sounds | |||||
during physical | The SimpleSENSE offers | ||||
the same ECG measures | |||||
as the SimplECG; heart | |||||
sounds as in the Eko | |||||
device, and a subset of | |||||
the measures included in | |||||
the Edan Patient Monitor | |||||
device. | |||||
The absence of the | |||||
measures does not affect | |||||
the substantial | |||||
equivalence of the New | |||||
Device. | |||||
Characteristic | Nanowear Inc. | ||||
SimpleSENSE - New | |||||
Device | |||||
Current Submission | Nanowear Inc. SimplECG | ||||
K161431 | Edan Instruments, Patient | ||||
Monitor, models elite V5, | |||||
elite V6 and elite V8 | |||||
K160981 | Eko Devices Inc. Eko | ||||
Electronic | |||||
Stethoscope System | |||||
K151319 | Comparison | ||||
recordings are indicated for | |||||
the manual assessment of | |||||
cardiac rhythm | |||||
disturbances. The device | |||||
does not produce alarms | |||||
and is not intended for | |||||
active patient | |||||
monitoring(real-time). The | |||||
device is not intended for | |||||
use as life supporting | |||||
equipment on high-risk | |||||
patients such as critical care | |||||
patients. The device is not | |||||
intended for use in the | |||||
presence of a pacemaker. | and impedance | ||||
cardiography (ICG). BIS is | |||||
intended for use on adult | |||||
and pediatric patients. | |||||
ICG monitoring is intended | |||||
for use on adults only. The | |||||
arrhythmia detection and | |||||
ST Segment analysis are | |||||
intended for adult patients. | |||||
The monitors are | |||||
additionally intended for | |||||
use during patient | |||||
transport inside hospitals. | |||||
The monitors are not | |||||
intended for MRI | |||||
environments. | examination in normal | ||||
patients or those with | |||||
suspected diseases of | |||||
the cardiac, vascular, | |||||
pulmonary or | |||||
abdominal organ | |||||
systems. | |||||
Product Code(s) | DXH, DPS, DQD, DSB, BZQ | DXH | MHX, DSI, DRT, CBQ, DXN, | ||
DSK, CBR, DQA, NHO, CBS, | |||||
NHQ, NHP, CCK, DSB, CCL, | |||||
BZQ, BZK, DPS, FLL, DRG, | |||||
MLD | DQD | Similar | |||
Characteristic | Nanowear Inc. | ||||
SimpleSENSE - New | |||||
Device | |||||
Current Submission | Nanowear Inc. SimplECG | ||||
K161431 | Edan Instruments, Patient | ||||
Monitor, models elite V5, | |||||
elite V6 and elite V8 | |||||
K160981 | Eko Devices Inc. Eko | ||||
Electronic | |||||
Stethoscope System | |||||
K151319 | Comparison | ||||
Acquired Data | Electrocardiogram | ||||
(EKG/ECG) | |||||
Respiration Rate derived | |||||
from thoracic impedance | |||||
Heart Sounds | Electrocardiogram | ||||
(EKG/ECG) | ECG, Respiration Rate, | ||||
Temperature SpO2, pulse | |||||
rate non-invasive blood | |||||
pressure (NIBP), invasive | |||||
blood pressure (IBP), | |||||
carbon dioxide (CO2), | |||||
cardiac output (C.O.), | |||||
anesthetic gas (AG), | |||||
Bispectral Index (BIS), | |||||
respiration mechanics (RM) | |||||
Impedance Cardiography | |||||
(ICG). | Heart Sounds | Same measures as those | |||
found in the predicate & | |||||
reference devices. The | |||||
New Device captures the | |||||
ECG signal in the same | |||||
way as the SimplECG | |||||
predicate. The New | |||||
Device captures some of | |||||
the measures in the Edan | |||||
reference and the heart | |||||
sounds as in the Eko | |||||
reference. The absence of | |||||
some measures does not | |||||
affect the substantial | |||||
equivalence of the | |||||
SimpleSENSE device. | |||||
Electrocardiogram | |||||
(EKG/ECG): Textile-based | |||||
Nanosensors | Electrocardiogram | ||||
(EKG/ECG): Textile-based | |||||
Nanosensors | Not Applicable | Not Applicable | Same sensors as in the | ||
SimplECG device are used | |||||
to capture signals | |||||
Sensor | |||||
Technology | Respiration Rate: Textile- | ||||
based Nanosensors | |||||
measure thoracic | |||||
impedance and | |||||
respiration is derived | |||||
from thoracic impedance | Not Applicable | Thoracic | |||
Impedance/Impedance | |||||
Cardiogram (ICG), ECG: | |||||
Disposable Silver or | |||||
Silver/Silver Chloride | |||||
electrode. | |||||
Respiration Rate: derived | |||||
from thoracic impedance | Not Applicable | Both the New Device and | |||
the Edan reference | |||||
measure and derive | |||||
respiration rate using | |||||
thoracic impedance | |||||
captured via a sensor. | |||||
The sensors in the two | |||||
devices are different, | |||||
however both types of | |||||
sensors are used for | |||||
Characteristic | Nanowear Inc. | ||||
SimpleSENSE - New | |||||
Device | |||||
Current Submission | Nanowear Inc. SimplECG | ||||
K161431 | Edan Instruments, Patient | ||||
Monitor, models elite V5, | |||||
elite V6 and elite V8 | |||||
K160981 | Eko Devices Inc. Eko | ||||
Electronic | |||||
Stethoscope System | |||||
K151319 | Comparison | ||||
physiologic signal capture | |||||
in other cleared devices. | |||||
Heart Sound: | |||||
Microelectromechanical | |||||
(MEMS) microphone | Not Applicable | Not Applicable | Heart Sound: Uses a | ||
standard stethoscope | |||||
diaphragm. Method of | |||||
transduction and | |||||
digitization of sound | |||||
waves is not Available | The SimpleSENSE device | ||||
uses a different sensor | |||||
than the Eko reference. | |||||
However, the signal | |||||
acquisition and location | |||||
used in both the | |||||
SimpleSENSE device and | |||||
the Eko reference are | |||||
similar. | |||||
Electrocardiogram | |||||
(EKG/ECG): Standard | |||||
Bipolar lead | |||||
instrumentation amplifier | |||||
and Sigma-Delta Analog | |||||
to Digital Converter. | Electrocardiogram | ||||
(EKG/ECG): Standard | |||||
Bipolar lead | |||||
instrumentation amplifier | |||||
and Sigma-Delta Analog to | |||||
Digital Converter | Not Applicable | Not Applicable | The signal acquisition | ||
method in the New Device | |||||
for capturing ECG signal is | |||||
the same as the SimplECG | |||||
predicate. | |||||
Signal | |||||
acquisition | |||||
method | Respiration rate: Thoracic | ||||
Impedance is measured | |||||
using four-point probe | |||||
using low amplitude | |||||
current applied to the | |||||
body and impedance | |||||
measured from voltage | |||||
drop derived from | |||||
thoracic impedance. | |||||
(Respiration Rate | |||||
detection range 6 - 22 | Not Applicable | Thoracic | |||
Impedance/Impedance | |||||
Cardiograph: four-point | |||||
probe using low amplitude | |||||
current applied to the body | |||||
and impedance measured | |||||
from voltage drop. | |||||
Respiration Rate: derived | |||||
from thoracic impedance | Not Applicable | The signal acquisition | |||
method for capturing | |||||
thoracic impedance is the | |||||
same as the Edan | |||||
reference. | |||||
Characteristic | Nanowear Inc. | ||||
SimpleSENSE - New | |||||
Device | |||||
Current Submission | Nanowear Inc. SimplECG | ||||
K161431 | Edan Instruments, Patient | ||||
Monitor, models elite V5, | |||||
elite V6 and elite V8 | |||||
K160981 | Eko Devices Inc. Eko | ||||
Electronic | |||||
Stethoscope System | |||||
K151319 | Comparison | ||||
breaths per minute (BPM) | |||||
with accuracy ± 2 BPM) | |||||
Heart Sound: solid state | |||||
Microelectromechanical | |||||
(MEMS) microphone | |||||
embedded in garment | |||||
and located near Apex of | |||||
heart. | Not Applicable | Not Applicable | Heart Sound: sensor | ||
embedded in a | |||||
standard stethoscope | |||||
attachment that can | |||||
amplify, digitize and | |||||
transmit data. | The signal acquisition | ||||
method for detecting | |||||
heart sounds is similar to | |||||
the Eko reference. Both | |||||
devices are placed in | |||||
similar locations to detect | |||||
and capture heart | |||||
sounds. | |||||
Display Type | No on-device display. | No on-device display. | On Device Display of | ||
waveforms acquired and | |||||
derived parameters is | |||||
available. Data can be | |||||
downloaded from the | |||||
device through an Ethernet | |||||
connection or a USB | |||||
connection. | No on-device display. | ||||
Display of data is | |||||
available on a | |||||
smartphone through a | |||||
smartphone app or on | |||||
the web using web | |||||
services. | Data display for the New | ||||
Device is the same as the | |||||
SimplECG predicate and | |||||
the Eko reference that | |||||
rely on wireless | |||||
transmission and display | |||||
on a smartphone or web- | |||||
based display. | |||||
Display | |||||
Requirement | User provided display | ||||
hardware for a | |||||
healthcare professional | |||||
to view the recorded | |||||
data. A general-purpose | |||||
PC/Laptop/Desktop or | |||||
mobile device may be | |||||
used. | User provided display | ||||
hardware for a healthcare | |||||
professional to view the | |||||
recorded data. A general- | |||||
purpose | |||||
PC/Laptop/Desktop may be | |||||
used. | No requirement for | ||||
additional user provided | |||||
hardware for display | Display available | ||||
through User provided | |||||
smartphone or tablet. | |||||
Display also available | |||||
through Web browser | |||||
on any | |||||
Laptop/PC/Desktop. | The Edan reference | ||||
includes a display | |||||
(hardware) while the New | |||||
Device, the SimplECG, and | |||||
the Eko reference all | |||||
display the data on the | |||||
user's hardware and via | |||||
web based display. | |||||
Power Source | Internally powered using | ||||
Li-Ion rechargeable | |||||
battery | Single Use Lithium AA type | ||||
batteries | Rechargeable Lithium-Ion | ||||
Battery and AC Mains | |||||
supported. | Internally powered | ||||
using Li-Ion | |||||
rechargeable battery | All of the devices are able | ||||
to operate on battery | |||||
power. The Edan | |||||
reference has an option | |||||
Characteristic | Nanowear Inc. | ||||
SimpleSENSE - New | |||||
Device | |||||
Current Submission | Nanowear Inc. SimplECG | ||||
K161431 | Edan Instruments, Patient | ||||
Monitor, models elite V5, | |||||
elite V6 and elite V8 | |||||
K160981 | Eko Devices Inc. Eko | ||||
Electronic | |||||
Stethoscope System | |||||
K151319 | Comparison | ||||
Internal | |||||
Memory/data | Removeable MicroSD | ||||
card | Removeable MicroSD card | Solid state memory non- | |||
removeable. | Solid state memory | ||||
non-removeable | All devices use memory | ||||
devices to store the data | |||||
collected. The New | |||||
Device and the SimplECG | |||||
predicate use removeable | |||||
cards while the Edan and | |||||
Eko references use non- | |||||
removable memory | |||||
devices. | |||||
Communication | |||||
Interface | Wireless transceiver | ||||
using Bluetooth | Wireless transceiver using | ||||
Bluetooth | USB connection or Ethernet | ||||
connection | Wireless transceiver | ||||
using Bluetooth | The New Device uses the | ||||
same communication | |||||
interface as the SimplECG | |||||
predicate and Eko | |||||
reference. The Edan | |||||
reference uses a non- | |||||
wireless interface. | |||||
Access to | |||||
recorded data | Data is transferred to the | ||||
iPhone, which is then | |||||
shared with the | |||||
healthcare professional. | |||||
For redundancy, | |||||
encrypted data is also | |||||
stored in the removeable | |||||
storage medium. | Data is transferred to the | ||||
iPhone, which is then | |||||
shared with the healthcare | |||||
professional. For | |||||
redundancy, encrypted | |||||
data is also stored in the | |||||
removeable storage | |||||
medium. Data is | |||||
transferred from the device | |||||
to a web server and a Web | |||||
interface is used to access | |||||
the data. | Trends data can be | ||||
downloaded using | |||||
proprietary clinical | |||||
management software. | Data is transferred | ||||
and stored in .wav | |||||
format and can be | |||||
retrieved from a web | |||||
interface | Access to the data output | ||||
for the New Device is the | |||||
same as the SimplECG and | |||||
similar to the Eko | |||||
reference. The Edan | |||||
reference uses proprietary | |||||
software to manage their | |||||
downloadable data. |
6
7
8
9
10
11
12
| Discussion -
similarities | The similarities of the New Device to one or more of the predicate/references are:
• Sensor technology is the same as the SimplECG predicate device sensor |
|------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | • Same measures as those found in the predicate and reference devices. |
| | • Same sensors as in the SimplECG device are used to capture signals (except heart
sounds) |
| | • Both the New Device and the Edan reference measure and derive respiration rate
using thoracic impedance captured via a sensor. |
| | • The signal acquisition method for capturing ECG signal is the same as the
SimplECG predicate. |
| | • The signal acquisition method for capturing thoracic impedance is the same as
the SimplECG predicate. |
| | • The signal acquisition method for detecting heart sounds is similar to the Eko
reference. Both devices are placed in similar locations to detect and capture
heart sounds. |
| | • Data display for the New Device is the same as the SimplECG predicate and Eko
reference that rely on wireless transmission and display on a smartphone or web-
based display. |
| | • The Edan reference includes a display (hardware) while the New Device, the
SimplECG predicate, and the Eko reference displays the data on the user's
hardware or via web based display. |
| | • All of the devices are able to operate on battery power. The Edan reference has
an additional option for use with an AC Main. |
| | • All of the devices listed use memory devices to store the data collected. The New
Device and the SimplECG predicate use removeable cards while the Edan and Eko
reference devices use non-removable memory devices. |
| | • The New Device uses the same communication interface as the SimplECG
predicate and Eko reference device. |
| | • Access to the data output for the New Device is the same as the SimplECG and
similar to the Eko reference. |
| Discussion -
differences | The differences between the New Device and the predicate/reference
devices are: |
| | • The New Device does not capture all of the measures in the Edan reference. |
| | • The sensors in the new device and Edan reference are different, however both
types of sensors are used for physiologic signal capture in other cleared devices. |
| | • The SimpleSENSE device uses a different sensor than the Eko reference.
However, the signal acquisition and location used in both the SimpleSENSE
device and the Eko reference are similar types of sensors. |
| | • The Edan reference uses a wired interface. |
| | • The Edan reference uses proprietary software to manage their downloadable
data. |
13
| Performance
testing | Performance testing for the SimpleSENSE device included the following:
• Verification of multiparametric data capture
• Verification of Bluetooth and iPhone connectivity
• Verification of encryption of acquired data
• Battery safety and charging status indication
• SAU performance and durability
• Durability, capacity, and data storage testing of the microSD card
• Battery charger verification
• Biocompatibility of the garment
• Electrocardiograph sensor performance
• Electrical current requirements for transthoracic impedance sensor
• MEMS microphone testing
• Garment conductive inlays testing for flexibility and electrical performance
• Garment compression requirements
• Garment fastening mechanisms
• Use cycles for the base garment
• Shelf life
• Equivalency testing against predicate/reference devices
Performance testing demonstrated performance to design specifications. |
|------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Conclusion | The performance data provided demonstrate that the SimpleSENSE device is
substantially equivalent to the indicated predicate device. |